200670 휴메딕스
기본 정보
- 섹터: KOSDAQ:제조
- 시가총액: 2,992억원 (2026-06-30 기준)
- 첫 등장: 2026-06-09 (누적 2일)
- 태그: 매크로/바이오헬스 · 히알루론산 · PDRN · 에스테틱 · CMO · 바이오
- 네이버 금융: 🔗
기업개요
- 동사는 2003년 기능성식품 제조 및 판매를 목적으로 설립되었으며, 2010년 휴메딕스로 상호 변경, 2014년 코스닥시장에 상장함.
- 히알루론산과 PDRN 연구개발을 통해 에스테틱 및 CMO 제품을 생산, 국내 및 글로벌 헬스케어 시장에 공급하고 있음.
- 에이치엘비제약, 제넨바이오, 지투지바이오, 에피바이오텍과의 파트너십을 통해 미래 성장 모멘텀을 확보하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-14 | 26,250 | 25,550 | 🔵 -2.67% | -0.57%p | ×1.0 | 🟡 금투 | -2.6억 | -2.6 | +0.0 | +1.9 | +0.0 | +0.7 | -0.0 |
| 2026-07-13 | 27,100 | 26,250 | 🔵 -3.14% | +0.00%p | ×1.3 | 🔻 개인 | -7.3억 | -7.3 | +0.0 | +2.0 | +0.0 | +5.3 | +0.0 |
| 2026-07-10 | 25,700 | 27,100 | 🔴 +5.45% | +0.78%p | ×0.9 | 🟢 외인 | +4.5억 | +4.5 | +0.0 | +2.0 | +0.0 | -6.5 | -0.0 |
| 2026-07-09 | 25,200 | 25,700 | 🔴 +1.98% | -0.80%p | ×1.4 | 🔻 개인 | -4.1억 | -4.1 | +0.0 | +2.0 | +0.0 | +2.0 | +0.1 |
| 2026-07-08 | 26,300 | 25,200 | 🔵 -4.18% | -4.75%p | ×0.9 | 🟡 금투 | +0.7억 | +0.7 | +0.0 | +2.0 | +0.0 | -0.7 | -2.1 |
| 2026-07-07 | 26,800 | 26,300 | 🔵 -1.87% | -0.56%p | ×0.9 | 🟡 금투 | -2.5억 | -2.5 | +0.0 | +1.8 | +0.0 | +0.7 | +0.0 |
| 2026-07-06 | 26,800 | 26,800 | ⚪ +0.00% | -0.93%p | ×0.8 | 🟡 금투 | -1.7억 | -1.7 | +0.0 | +2.0 | +0.0 | -0.1 | -0.2 |
| 2026-07-03 | 27,200 | 26,800 | 🔵 -0.56% | -0.19%p | ×1.0 | 🟡 금투 | -0.4억 | -0.4 | +0.0 | +2.0 | +0.0 | -1.6 | -0.0 |
| 2026-07-02 | 27,500 | 27,200 | 🔵 -1.09% | +0.91%p | ×0.9 | 🟡 금투 | -2.9억 | -2.9 | +0.0 | +2.4 | +0.0 | +0.6 | -0.1 |
| 2026-07-01 | 27,100 | 27,500 | 🔴 +1.48% | -0.18%p | ×0.7 | 🟡 금투 | -2.5억 | -2.5 | +0.0 | +2.1 | +0.0 | +0.5 | -0.1 |
| 2026-06-30 | 27,800 | 27,100 | 🔵 -2.52% | +1.62%p | ×0.8 | 🟡 금투 | -1.8억 | -1.8 | +0.0 | +1.9 | +0.0 | +0.1 | -0.2 |
| 2026-06-29 | 25,600 | 27,800 | 🔴 +8.59% | +0.39%p | ×1.2 | 🟢 외인 | +7.6억 | +7.6 | +0.0 | +2.2 | +0.0 | -8.6 | -1.1 |
| 2026-06-26 | 27,000 | 25,600 | 🔵 -5.19% | +1.11%p | ×1.4 | 🟡 금투 | -1.7억 | -1.7 | +0.0 | +1.9 | +0.0 | +0.1 | -0.3 |
| 2026-06-25 | 28,000 | 27,000 | 🔵 -3.57% | +0.89%p | ×0.9 | 🔻 개인 | -7.1억 | -7.1 | +0.0 | +1.9 | +0.0 | +5.5 | -0.3 |
| 2026-06-24 | 25,000 | 28,000 | ➕ 🔴 +12.00% | +2.40%p | ×1.4 | 🟡 금투 | +0.3억 | +0.3 | +0.0 | +2.1 | -0.0 | -2.8 | +0.4 |
| 2026-06-23 | 26,650 | 25,000 | 🔵 -6.19% | -1.31%p | ×1.1 | 🟡 금투 | +1.4억 | +1.5 | -0.1 | +1.9 | -3.2 | -0.1 | |
| 2026-06-22 | 26,400 | 26,650 | 🔴 +0.95% | +0.95%p | ×0.8 | 🟡 금투 | +0.4억 | +0.4 | +0.0 | +1.9 | -1.9 | -0.4 | |
| 2026-06-19 | 27,400 | 26,400 | 🔵 -3.65% | -1.64%p | ×1.6 | 🟡 금투 | -2.0억 | -2.0 | +0.0 | +1.9 | +0.3 | -0.1 | |
| 2026-06-18 | 28,950 | 27,400 | 🔵 -5.35% | -0.34%p | ×0.9 | 🔻 개인 | -4.0억 | -4.0 | +0.0 | +1.9 | +2.3 | -0.2 | |
| 2026-06-17 | 28,300 | 28,950 | 🔴 +2.30% | +0.71%p | ×0.7 | 🟡 금투 | -0.3억 | -0.2 | -0.1 | +2.1 | -1.6 | -0.1 | |
| 2026-06-16 | 28,800 | 28,300 | 🔵 -1.74% | +0.69%p | ×0.6 | 🟡 금투 | -1.6억 | -1.6 | +0.0 | +1.9 | +0.5 | -0.9 | |
| 2026-06-15 | 28,300 | 28,800 | 🔴 +1.77% | +0.00%p | ×0.8 | 🟡 금투 | -3.0억 | -3.0 | +0.0 | +2.3 | +0.9 | -0.3 | |
| 2026-06-12 | 27,550 | 28,300 | 🔴 +2.72% | +0.00%p | ×1.3 | 🟡 금투 | -2.4억 | -2.4 | +0.0 | +4.0 | -3.0 | +1.4 | |
| 2026-06-11 | 26,250 | 27,550 | 🔴 +4.95% | -0.19%p | ×0.7 | 🔻 개인 | -2.4억 | -2.4 | +0.0 | +0.0 | +2.1 | +0.3 | |
| 2026-06-10 | 27,250 | 26,250 | 🔵 -3.67% | -0.18%p | ×1.1 | ⚫ 그외 | +0.3억 | +0.3 | +0.0 | +0.1 | -1.0 | +0.5 | |
| 2026-06-09 | 24,550 | 27,250 | ➕ 🔴 +11.00% | +4.28%p | ×1.0 | 🟢 외인 | +3.8억 | +3.8 | +0.0 | +0.1 | -2.6 | -1.2 | |
| 2026-06-08 | 25,250 | 24,550 | 🔵 -2.77% | +0.60%p | ×1.2 | 🟢 외인 | +1.2억 | +1.2 | +0.0 | +0.0 | -0.8 | -0.5 | |
| 2026-06-05 | 26,100 | 25,250 | 🔵 -3.26% | -0.58%p | ×0.6 | 🔻 개인 | +0.0억 | +0.0 | +0.0 | -0.1 | +0.1 | -0.1 | |
| 2026-06-04 | 26,600 | 26,100 | 🔵 -1.88% | -0.94%p | ×0.6 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | -0.1 | +2.1 | -1.6 | |
| 2026-06-02 | 26,600 | 26,600 | ⚪ +0.00% | +0.75%p | ×0.5 | 🟢 외인 | +3.7억 | +3.7 | +0.0 | +0.0 | -4.7 | +0.9 | |
| 2026-06-01 | 27,400 | 26,600 | 🔵 -2.92% | -0.91%p | ×0.6 | 🟢 외인 | +5.0억 | +5.0 | +0.0 | -0.0 | -4.8 | -0.1 | |
| 2026-05-29 | 27,950 | 27,400 | 🔵 -1.97% | -0.18%p | ×0.7 | 🔻 개인 | -3.5억 | -3.5 | +0.0 | +0.0 | +4.9 | -1.4 | |
| 2026-05-28 | 28,750 | 27,950 | 🔵 -2.78% | -1.21%p | ×0.6 | 🔻 개인 | -0.6억 | -0.6 | +0.0 | -0.0 | +0.8 | -0.1 | |
| 2026-05-27 | 29,350 | 28,750 | 🔵 -2.04% | +0.17%p | ×0.6 | 🟢 외인 | +1.2억 | +1.2 | +0.0 | +0.1 | -1.2 | -0.1 | |
| 2026-05-26 | 30,500 | 29,350 | 🔵 -3.77% | +0.49%p | ×0.9 | 🔻 개인 | -10.1억 | -10.1 | +0.0 | +0.3 | +9.9 | -0.1 | |
| 2026-05-22 | 29,200 | 30,500 | 🔴 +4.45% | -0.34%p | ×0.8 | 🟢 외인 | +6.1억 | +6.1 | +0.0 | +1.1 | -7.8 | +0.6 |
일자별 사유 (최신 위)
2026-06-24
- 사유: 골관절염 주사제 브라질 수출 개시
- 섹터 컨텍스트: KOSDAQ:제조 (smart -788억)
- 매크로 원인: 코스피 급락 후 반등 속 제약·바이오 동반 급등(516종목 상승)에 종목별 개별 호재 가세 (보통)
2026-06-09
- 사유: 50억 자사주 취득 신탁계약 체결+IR
- 섹터 컨텍스트: KOSDAQ:제조 (smart +1,603억)
- 매크로 원인: 코스피·코스닥 급반등 동조 + 美당뇨학회 비만약·ADC 기술수출 K바이오 모멘텀, 개별 호재 가세 (보통)